RHUMBLINE ADVISERS - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 117 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$562,470
+39.2%
99,554
+1.3%
0.00%
Q1 2024$404,099
-4.2%
98,324
-1.7%
0.00%
Q4 2023$422,012
-4.2%
100,006
-1.9%
0.00%
-100.0%
Q3 2023$440,368
-67.0%
101,941
-49.7%
0.00%0.0%
Q2 2023$1,335,845
+101485.2%
202,708
+4.7%
0.00%
-50.0%
Q1 2023$1,315
-3.9%
193,608
+4.6%
0.00%0.0%
Q4 2022$1,368
-99.9%
185,123
+5.4%
0.00%
-33.3%
Q3 2022$1,735,000
-9.1%
175,642
+0.4%
0.00%0.0%
Q2 2022$1,908,000
+2.0%
175,028
+5.8%
0.00%
+50.0%
Q1 2022$1,871,000
-29.3%
165,417
-1.9%
0.00%
-33.3%
Q4 2021$2,645,000
-9.9%
168,566
-1.6%
0.00%
-25.0%
Q3 2021$2,936,000
-28.8%
171,309
-10.6%
0.00%
-20.0%
Q2 2021$4,124,000
+36.7%
191,724
-4.6%
0.01%
+25.0%
Q1 2021$3,017,000
+14.1%
200,871
-0.2%
0.00%0.0%
Q4 2020$2,644,000
+49.3%
201,180
+9.8%
0.00%
+33.3%
Q3 2020$1,771,000
-22.2%
183,307
-7.8%
0.00%
-25.0%
Q2 2020$2,275,000
+25.1%
198,880
+13.3%
0.00%0.0%
Q1 2020$1,818,000
-35.7%
175,530
+1.8%
0.00%
-20.0%
Q4 2019$2,829,000
+30.2%
172,367
+5.4%
0.01%
+25.0%
Q3 2019$2,173,000
-2.8%
163,597
+3.1%
0.00%0.0%
Q2 2019$2,235,000
-19.0%
158,602
+5.8%
0.00%
-20.0%
Q1 2019$2,759,000
-29.2%
149,949
+0.6%
0.01%
-37.5%
Q4 2018$3,896,000
+24.0%
149,117
+8.9%
0.01%
+33.3%
Q3 2018$3,142,000
+220.0%
136,921
+165.6%
0.01%
+200.0%
Q2 2018$982,000
+38.1%
51,551
+22.2%
0.00%
+100.0%
Q1 2018$711,000
+8.2%
42,186
-2.3%
0.00%0.0%
Q4 2017$657,000
-28.5%
43,196
-15.8%
0.00%
-50.0%
Q3 2017$919,000
+11.1%
51,321
+1.2%
0.00%0.0%
Q2 2017$827,000
+33.0%
50,721
+14.2%
0.00%
+100.0%
Q1 2017$622,000
-9.1%
44,422
+3.6%
0.00%
-50.0%
Q4 2016$684,000
+3.6%
42,872
+8.0%
0.00%0.0%
Q3 2016$660,000
+32.8%
39,684
-10.7%
0.00%
+100.0%
Q2 2016$497,000
+30.1%
44,434
-2.8%
0.00%0.0%
Q1 2016$382,000
-7.5%
45,693
+2.9%
0.00%0.0%
Q4 2015$413,000
-12.7%
44,408
+6.0%
0.00%
-50.0%
Q3 2015$473,000
-10.4%
41,893
+0.7%
0.00%0.0%
Q2 2015$528,000
+47.1%
41,610
+7.7%
0.00%
+100.0%
Q1 2015$359,000
-13.7%
38,645
+33.2%
0.00%0.0%
Q4 2014$416,000
+34.6%
29,020
-2.6%
0.00%0.0%
Q3 2014$309,000
-35.9%
29,7950.0%0.00%0.0%
Q2 2014$482,000
+4.1%
29,795
+4.5%
0.00%0.0%
Q1 2014$463,000
+25.1%
28,522
-4.3%
0.00%0.0%
Q4 2013$370,000
+20.5%
29,802
+6.5%
0.00%0.0%
Q3 2013$307,000
+42.8%
27,992
+5.3%
0.00%0.0%
Q2 2013$215,00026,5800.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 728,000$10,425,0005.01%
Signpost Capital Advisors, LP 828,793$11,868,0004.38%
Palo Alto Investors LP 3,786,908$54,229,0003.18%
RTW INVESTMENTS, LP 500,000$7,160,0002.65%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,139,787$59,282,0002.13%
First Light Asset Management, LLC 229,818$3,291,0001.86%
KINGDON CAPITAL MANAGEMENT, L.L.C. 2,461,305$35,246,0001.53%
PURA VIDA INVESTMENTS, LLC 175,000$2,506,0000.92%
WALL STREET ASSOCIATES 655,800$9,391,0000.90%
SPHERA FUNDS MANAGEMENT LTD. 368,390$5,275,0000.90%
View complete list of VANDA PHARMACEUTICALS INC shareholders